Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | PTC596 |
Synonyms | |
Therapy Description |
PTC596 is a small molecule inhibitor of BMI-1, which may result in mitochondrial induced apoptosis in cancer cells (PMID: 28211885, PMID: 32232850, PMID: 31934644). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
PTC596 | PTC596 is a small molecule inhibitor of BMI-1, which may result in mitochondrial induced apoptosis in cancer cells (PMID: 28211885, PMID: 32232850, PMID: 31934644). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02404480 | Phase I | PTC596 | PTC596 in Patients With Advanced Solid Tumors | Completed | USA | CAN | 0 |
NCT03605550 | Phase I | PTC596 | A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma | Recruiting | USA | 0 |